2024 HCPCS Code J9371
Injection, vincristine sulfate liposome, 1 mg
TAGS: vincristine sulfate
| Notice | HCPCS J9371 terminated on June 30, 2024. |
| Short Description | Inj, vincristine sul lip 1mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | D - Discontinue procedure or modifier code |
| HCPCS Action Effective Date | July 01, 2024 |
| HCPCS Code Added Date | January 01, 2014 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9349 - Inj., tafasitamab-cxix
- J9350 - Inj mosunetuzumab-axgb, 1 mg
- J9351 - Topotecan injection
- J9352 - Injection trabectedin 0.1mg
- J9353 - Inj. margetuximab-cmkb, 5 mg
- J9354 - Inj, ado-trastuzumab emt 1mg
- J9355 - Inj trastuzumab excl biosimi
- J9356 - Inj. herceptin hylecta, 10mg
- J9357 - Valrubicin injection
- J9358 - Inj fam-trastu deru-nxki 1mg
- J9359 - Inj lon tesirin-lpyl 0.075mg
- J9360 - Vinblastine sulfate inj
- J9361 - Inj, efbemalenograstim alfa-
- J9370 - Vincristine sulfate 1 mg inj
- J9371 - Inj, vincristine sul lip 1mg
- J9376 - Inj pozelimab-bbfg, 1 mg
- J9380 - Inj teclistamab cqyv 0.5 mg
- J9381 - Inj teplizumab mzwv 5 mcg
- J9390 - Vinorelbine tartrate inj
- J9393 - Inj, fulvestrant (teva)